Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing NaN - NaN of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 17, 2023

Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)

Recruiting
  • Solid Tumor
  • +4 more
  • AB248
  • Pembrolizumab
  • Lafayette, Indiana
  • +2 more
Jan 25, 2023

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • La Jolla, California
  • +159 more
Jan 23, 2023

Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Ipilimumab, Ipilimumab )

Active, not recruiting
  • Renal Cell Carcinoma
  • Nivolumab
  • +2 more
  • Washington, District of Columbia
  • +77 more
Jan 6, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Soft Tissue Sarcoma, Renal Cell Carcinoma, Uterine Carcinosarcoma Trial in United States (HFB301001)

Recruiting
  • Soft Tissue Sarcoma
  • +4 more
  • Scottsdale, Arizona
  • +9 more
Sep 13, 2022

Study of Kidney Tumors in Younger Patients

Recruiting
  • Adult Cystic Nephroma
  • +24 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +247 more
Sep 2, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Renal Cell Carcinoma Trial in Worldwide (Lenvatinib, Everolimus, Pembrolizumab)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Stanford, California
  • +182 more
Jul 1, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Renal Cell Carcinoma
  • IPI-549 (eganelisib)
  • +3 more
  • Chandler, Arizona
  • +23 more
Apr 1, 2022

Cancer, Solid Tumor, Melanoma Trial in United States (ST-067)

Recruiting
  • Cancer
  • +7 more
  • ST-067
  • Scottsdale, Arizona
  • +3 more
Mar 21, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,

Recruiting
  • Solid Tumor
  • +8 more
  • TBio-6517
  • Pembrolizumab
  • Phoenix, Arizona
  • +10 more
Feb 21, 2022

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +2 more
  • Tucson, Arizona
  • +153 more
Jan 13, 2022

Metastatic Castration-resistant Prostrate Cancer, Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (BMS-936558

Completed
Has Results
  • Metastatic Castration-resistant Prostrate Cancer
  • +3 more
  • BMS-936558 (MDX-1106)
  • Scottsdale, Arizona
  • +12 more
Dec 1, 2021